MRC Technology extends reach

After six years of focusing on developing small molecule drug candidates and humanizing therapeutic mAbs, both mostly from U.K. source, MRC Technology, the commercialization arm of the country's Medical Research Council, is taking its search for new assets to Asia. MRC Technology has taken its first steps on that front through a deal with the Shanghai Institute of Biochemistry and Cell Biology, part of the Chinese Academy of Sciences.

The MRC is the U.K.'s largest publicly funded biomedical research organization. MRC Technology initially provided technology transfer services exclusively to MRC but now works with multiple charitable and academic organizations...